159922-68-6 Usage
Description
4-METHOXYPHENYL 2,6-DI-O-BENZYL-3,4-O-ISOPROPYLIDENE-BETA-D-GALACTOPYRANOSIDE, with the CAS number 159922-68-6, is a complex carbohydrate derivative that plays a significant role in the field of biochemistry and pharmaceuticals. It is characterized by its unique structure, which includes a 4-methoxyphenyl group, benzyl moieties, and an isopropylidene bridge. 4-METHOXYPHENYL 2,6-DI-O-BENZYL-3,4-O-ISOPROPYLIDENE-BETA-D-GALACTOPYRANOSIDE is known for its potential applications in the synthesis of various biologically active molecules.
Uses
Used in Pharmaceutical Industry:
4-METHOXYPHENYL 2,6-DI-O-BENZYL-3,4-O-ISOPROPYLIDENE-BETA-D-GALACTOPYRANOSIDE is used as a key intermediate in the synthesis of sulfated glycosphingolipid SM1a, which is a human epithelial carcinoma antigen. This application is significant because the synthesis of such antigens can contribute to the development of targeted therapies and diagnostic tools for cancer.
The compound's role in the synthesis of biologically relevant molecules highlights its potential utility in the pharmaceutical industry, particularly in the development of novel drugs and therapies for various diseases, including cancer. Its unique structural features make it an attractive candidate for further research and development in the field of medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 159922-68-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,9,9,2 and 2 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 159922-68:
(8*1)+(7*5)+(6*9)+(5*9)+(4*2)+(3*2)+(2*6)+(1*8)=176
176 % 10 = 6
So 159922-68-6 is a valid CAS Registry Number.
InChI:InChI=1/C30H34O7/c1-30(2)36-26-25(20-32-18-21-10-6-4-7-11-21)35-29(34-24-16-14-23(31-3)15-17-24)28(27(26)37-30)33-19-22-12-8-5-9-13-22/h4-17,25-29H,18-20H2,1-3H3/t25-,26+,27+,28-,29-/m1/s1
159922-68-6Relevant articles and documents
Total synthesis of sulfated glycosphingolipid SM1a, a kind of human epithelial carcinoma antigen
Zhang, Pengtao,Wang, Kun,Zhang, Jun,Li, Chunxia,Guan, Huashi
, p. 570 - 583 (2015/01/30)
A highly efficient and practical total synthesis of the sulfated ganglioside SM1a, a kind of human epithelial carcinoma antigen identified in mammalian kidney, has been accomplished for the first time. The characteristic sequence of SM1a, β-D-Galp-(1→3)-β
Synthesis of some blocked di- and trisaccharide derivatives related to the repeating unit of the O-antigen from Shigella dysenteriae type 3 in the form of their glycosides
Sarkar, Sujit Kumar,Roy, Nirmolendu
, p. 2386 - 2394 (2007/10/03)
Starting from D-galactose and D-galactosamine hydrochloride, two new monosaccharide synthons namely 2-(trimethylsilyl)ethyl 4-O-acetyl-2,6-di-O- benzyl-β-D-galactopyranoside 2 and phenyl 3-O-acetyl-4,6-O-benzylidene-2- deoxy-2-phthalimido-1-thio-β-D-galac
SYNTHESIS OF HUMAN M BLOOD GROUP ANTIGENIC GLYCOPEPTIDE
Nakahara, Yoshiaki,Iijima, Hiroyuki,Ogawa, Tomoya
, p. 3321 - 3324 (2007/10/02)
A first total synthesis of terminal glycoheptapeptide of human glycophorin AM was accomplished by solution phase peptide condensation utilizing the tetrasaccharide-linked amino acid building blocks designed for Fmoc strategy.